Blake Wu
Investing Profile
Sweet spot: $25M
Range: $2M–$50M
Fund: $6.2B
Sector and stage focus
- Series B: BioTech, Pharmaceuticals, Health & Hospital Services, Health IT
- Series A: BioTech, Health IT, Pharmaceuticals, Health & Hospital Services
- general: San Francisco Bay Area
Recent investments by Blake Wu
Blake Wu has 7 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Slope.io | Series A | Oct 2021 | $20M |
| House Rx | Series B | Nov 2025 | $55M |
| Popai Health | Seed | Nov 2025 | $11M |
| In-House Health | Seed | May 2024 | $4M |
| Phathom Pharmaceuticals | Post Ipo Equity | May 2023 | $150M |
| Savara Pharmaceuticals | Post Ipo Equity | Mar 2021 | $130M |
| Translucent AI | Seed | Aug 2025 | $7M |
Frequent co-investors
Blake Wu has co-invested with: Paul Walker, Hadley Harris, Vic Singh, Mohamad Makhzoumi.
Is Blake Wu a fit for your round?
Upload your pitch deck and see whether Blake Wu appears in your top 20 matches.
Find investors for your deck